Harbour Investments Inc. Acquires 203 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Harbour Investments Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 6,802 shares of the healthcare conglomerate’s stock after purchasing an additional 203 shares during the period. Harbour Investments Inc.’s holdings in UnitedHealth Group were worth $3,441,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of UNH. Centurion Wealth Management LLC grew its position in UnitedHealth Group by 2.9% during the 4th quarter. Centurion Wealth Management LLC now owns 3,025 shares of the healthcare conglomerate’s stock worth $1,530,000 after acquiring an additional 86 shares during the last quarter. Ascent Capital Management LLC bought a new stake in UnitedHealth Group during the 4th quarter worth $493,000. Hutchinson Capital Management CA grew its position in UnitedHealth Group by 0.5% during the 4th quarter. Hutchinson Capital Management CA now owns 33,503 shares of the healthcare conglomerate’s stock worth $16,948,000 after acquiring an additional 173 shares during the last quarter. Avalon Trust Co grew its position in UnitedHealth Group by 5.8% during the 4th quarter. Avalon Trust Co now owns 2,755 shares of the healthcare conglomerate’s stock worth $1,394,000 after acquiring an additional 152 shares during the last quarter. Finally, one8zero8 LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $4,286,000. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

UNH has been the topic of a number of analyst reports. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH opened at $488.52 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a 50 day moving average price of $511.36 and a two-hundred day moving average price of $549.80. The firm has a market capitalization of $446.85 billion, a P/E ratio of 31.52, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.72%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.